Benzinga's Top Pre-Market NASDAQ Gainers (ITMN, YRCW, TTWO, ORCL)

InterMune Inc

rose 121.37% to $31.59 in the pre-market session. The Committee for Medicinal Products for Human Use (

) of the European Medicines Agency (EMA) has backed the ITMN's experimental lung drug Esbriet. YRC Worldwide Inc

added 8.38% to $3.62 in the pre-market session. YRCW's shares have dipped 85.79% over the past 52 weeks, while the S&P 500 index has gained 13.39% in the same period. Take-Two Interactive Software Inc

moved up 6.78% to $12.75 in the pre-market session. TTWO swung to a Q4 profit of $0.58 per share, from a loss of $0.30 per share, in the year-ago quarter. Oracle Corp

soared 4.69% to $31.69 in the pre-market trading. ORCL reported 47% y/y surge in its FQ2 revenue. Read more